The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / The Fluid Future of Liquid Biopsy
Oncology Liquid biopsy Omics Precision medicine Technology and innovation Molecular Pathology

The Fluid Future of Liquid Biopsy

Clinical lab scientists will help expand ctDNA applications from what can be measured to what should be measured, and why

By Patrick Hurban 10/14/2026 Discussion 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

5 Topic Commentaries

The Fluid Future of Liquid Biopsy

The Fluid Future of Liquid Biopsy

  • Christos Patriotis
    Christos Patriotis, PhD, MSc

    Cancer prevention; Biomarker development

    •

    National Cancer Institute, NIH (Division of Cancer Prevention)

    We hope that in the next three, four, five years, liquid biopsies will start becoming routine in the clinic, — verbatim from source

    Source
  • Aadel A. Chaudhuri
    Aadel A. Chaudhuri, MD, PhD

    Radiation oncology; Liquid biopsy

    •

    Mayo Clinic

    This is the first time we've been able to noninvasively profile the tumor microenvironment at this level, — verbatim from source

    Source
  • Paula Hurley
    Paula Hurley, PhD

    Urologic oncology; Cancer genomics

    •

    Johns Hopkins Medicine

    It is also much better at capturing differences in cancer cells between cancer sites. — verbatim from source

    Source
  • Robin Mendelsohn
    Robin Mendelsohn, MD

    Gastroenterology; Colorectal cancer screening

    •

    Memorial Sloan Kettering Cancer Center

    Obviously, we would love to have blood tests that could detect cancer early, before there are any signs or symptoms. — verbatim from source

    Source
  • Julie R. Gralow
    Julie R. Gralow, MD, FACP, FASCO

    Medical oncology

    •

    American Society of Clinical Oncology (ASCO)

    Nevertheless, these findings still offer genuine hope for deadly malignancies that currently lack screening options, such as ovarian and pancreatic cancer. — verbatim from source

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Patrick Hurban

Patrick Hurban, PhD, is a seasoned scientific leader at IQVIA Laboratories, currently serving as Chief Scientific Officer for Laboratories and Design and Delivery Innovation. In this role, he drives global scientific strategy and innovation across laboratory services supporting clinical development. Patrick previously led genomics and translational science operations worldwide and spent over a decade heading translational genomics. Over more than 25 years in molecular genetics and RandD, Patrick has built high-performing teams that advance precision medicine and clinical research.

More Articles by Patrick Hurban

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.